Archives

House Draft Bill Proposes Immediate Expensing for Section 174 R&D Costs

Among the handful of provisions in the House draft legislative package, called “The One, Big, Beautiful Bill,” is a long-awaited change…

Bridget UribeMay 16, 2025

Articles Business Tax Life Sciences & Pharma

Transfer Pricing Considerations for Pharmaceutical Companies

In a prior article, we discussed the basics of transfer pricing (The Basics of Transfer Pricing). The focus of this…

Chris FrederickMay 5, 2025

Articles Business Tax Life Sciences & Pharma

Payroll Tax Credit for Pre-Revenue Life Science Companies

The Credit for Increasing Research Activities under Internal Revenue Code Section 41 is a Federal tax credit that, in most…

Kurt ReinhardtApril 7, 2025

Articles Business Tax Life Sciences & Pharma

Chargebacks in the Pharmaceutical Industry: Understanding the Data

In the past, we have written about the basics of chargebacks (Deduction Rules for Accrued Liabilities: Chargebacks Edition), a significant…

Chris FrederickMarch 6, 2025

Articles Business Tax Life Sciences & Pharma

Expected IRS R&D Credit Form Changes and Potential Opportunities

The IRS has recently released a new draft of Form 6765, "Credit for Increasing Research Activities," aimed at expanding the…

Tim TorresFebruary 10, 2025

Client Accounting Advisory Services International Commerce Group International Tax Life Sciences & Pharma Multimedia WG Podcast

Certification of U.S. Tax Residency

Join host Chris Frederick and partner Darko Naumoski as they dive into the intricacies of U.S. tax residency, exploring how…

WilkinGuttenplanOctober 8, 2024

Emerging Entrepreneurs International Commerce Group Life Sciences & Pharma Multimedia

Navigating Borders: Challenges of Indian Businesses Expanding to the U.S.

Partner ⁠Vinay Navani,⁠ and host ⁠Chris Frederick,⁠ kick off Season 3 with an episode discussing the key obstacles businesses may face when looking to…

Vinay NavaniJanuary 2, 2024

Articles Business Tax Life Sciences & Pharma

Licensing or Sale of Intellectual Property

Collaboration agreements are often seen as a means for life sciences, biotechnology, and other companies to share the risks often…

Tim TorresDecember 7, 2023

Articles Business Tax Life Sciences & Pharma

Licensing or Sale of Intellectual Property in a Collaboration Agreement

Collaboration agreements are often seen as a means for life sciences, biotechnology, and other companies to share the risks often…

Tim TorresDecember 5, 2023

Articles Business Tax Life Sciences & Pharma

Collaboration or Partnership: Defining Which Is Best

Today’s economy is strife with soaring costs, and every business feels the impact. Look no further than development-stage life science…

Tim TorresNovember 30, 2023

Life Sciences & Pharma

Menu